Selective inactivation of viruses with femtosecond laser pulses and its potential use for in vitro therapy

Shaw Wei D Tsen, Yu Shan D Tsen, K. T. Tsen, Tzyy Choou Wu

Research output: Contribution to journalArticle

Abstract

Introduction: Traditional biochemical and pharmaceutical methods employed today encounter problems of clinical side effects and drug resistance, and their use is becoming limited. Therefore, it has become important and necessary to develop new, alternative strategies to combat viral diseases. Materials and Method: Avariety of viruses including M13 bacetriophage (nonenveloped ssDNA), tobacco mosaic virus (nonenveloped ssRNA), human papillomavirus (nonenveloped dsDNA) and human immunodeficiency virus (enveloped ssRNA), together with human red blood cells, Jurkat T-cells and mouse dendritic cells in their buffer solutions have been irradiated with near-infrared subpicosecond laser pulses in vitro. Results: A window of laser power density, approximately between 1 GW/cm2 and 10 GW/cm2, has been observed that allows killing the viral particles while leaving mammalian cells unharmed. Conclusion: The ultrashort pulsed laser technology may have great potential for disinfection of blood components.

Original languageEnglish (US)
Pages (from-to)185-196
Number of pages12
JournalJournal of Healthcare Engineering
Volume1
Issue number2
DOIs
StatePublished - Jun 2010

Fingerprint

Virus Inactivation
Ultrashort pulses
Viruses
Lasers
Blood
Cells
Tobacco Mosaic Virus
Jurkat Cells
T-cells
Tobacco
Infrared lasers
Disinfection
Virus Diseases
Drug-Related Side Effects and Adverse Reactions
Pulsed lasers
Drug Resistance
Virion
Drug products
Dendritic Cells
Laser pulses

Keywords

  • Femtosecond laser
  • Selective inactivation
  • Viruses

ASJC Scopus subject areas

  • Biomedical Engineering
  • Health Informatics
  • Biotechnology
  • Surgery

Cite this

Selective inactivation of viruses with femtosecond laser pulses and its potential use for in vitro therapy. / Tsen, Shaw Wei D; Tsen, Yu Shan D; Tsen, K. T.; Wu, Tzyy Choou.

In: Journal of Healthcare Engineering, Vol. 1, No. 2, 06.2010, p. 185-196.

Research output: Contribution to journalArticle

@article{e22467f50ae5410c8d49d2651836e6ad,
title = "Selective inactivation of viruses with femtosecond laser pulses and its potential use for in vitro therapy",
abstract = "Introduction: Traditional biochemical and pharmaceutical methods employed today encounter problems of clinical side effects and drug resistance, and their use is becoming limited. Therefore, it has become important and necessary to develop new, alternative strategies to combat viral diseases. Materials and Method: Avariety of viruses including M13 bacetriophage (nonenveloped ssDNA), tobacco mosaic virus (nonenveloped ssRNA), human papillomavirus (nonenveloped dsDNA) and human immunodeficiency virus (enveloped ssRNA), together with human red blood cells, Jurkat T-cells and mouse dendritic cells in their buffer solutions have been irradiated with near-infrared subpicosecond laser pulses in vitro. Results: A window of laser power density, approximately between 1 GW/cm2 and 10 GW/cm2, has been observed that allows killing the viral particles while leaving mammalian cells unharmed. Conclusion: The ultrashort pulsed laser technology may have great potential for disinfection of blood components.",
keywords = "Femtosecond laser, Selective inactivation, Viruses",
author = "Tsen, {Shaw Wei D} and Tsen, {Yu Shan D} and Tsen, {K. T.} and Wu, {Tzyy Choou}",
year = "2010",
month = "6",
doi = "10.1260/2040-2295.1.2.185",
language = "English (US)",
volume = "1",
pages = "185--196",
journal = "Journal of Healthcare Engineering",
issn = "2040-2295",
publisher = "Multi Science Publishing",
number = "2",

}

TY - JOUR

T1 - Selective inactivation of viruses with femtosecond laser pulses and its potential use for in vitro therapy

AU - Tsen, Shaw Wei D

AU - Tsen, Yu Shan D

AU - Tsen, K. T.

AU - Wu, Tzyy Choou

PY - 2010/6

Y1 - 2010/6

N2 - Introduction: Traditional biochemical and pharmaceutical methods employed today encounter problems of clinical side effects and drug resistance, and their use is becoming limited. Therefore, it has become important and necessary to develop new, alternative strategies to combat viral diseases. Materials and Method: Avariety of viruses including M13 bacetriophage (nonenveloped ssDNA), tobacco mosaic virus (nonenveloped ssRNA), human papillomavirus (nonenveloped dsDNA) and human immunodeficiency virus (enveloped ssRNA), together with human red blood cells, Jurkat T-cells and mouse dendritic cells in their buffer solutions have been irradiated with near-infrared subpicosecond laser pulses in vitro. Results: A window of laser power density, approximately between 1 GW/cm2 and 10 GW/cm2, has been observed that allows killing the viral particles while leaving mammalian cells unharmed. Conclusion: The ultrashort pulsed laser technology may have great potential for disinfection of blood components.

AB - Introduction: Traditional biochemical and pharmaceutical methods employed today encounter problems of clinical side effects and drug resistance, and their use is becoming limited. Therefore, it has become important and necessary to develop new, alternative strategies to combat viral diseases. Materials and Method: Avariety of viruses including M13 bacetriophage (nonenveloped ssDNA), tobacco mosaic virus (nonenveloped ssRNA), human papillomavirus (nonenveloped dsDNA) and human immunodeficiency virus (enveloped ssRNA), together with human red blood cells, Jurkat T-cells and mouse dendritic cells in their buffer solutions have been irradiated with near-infrared subpicosecond laser pulses in vitro. Results: A window of laser power density, approximately between 1 GW/cm2 and 10 GW/cm2, has been observed that allows killing the viral particles while leaving mammalian cells unharmed. Conclusion: The ultrashort pulsed laser technology may have great potential for disinfection of blood components.

KW - Femtosecond laser

KW - Selective inactivation

KW - Viruses

UR - http://www.scopus.com/inward/record.url?scp=79954497548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954497548&partnerID=8YFLogxK

U2 - 10.1260/2040-2295.1.2.185

DO - 10.1260/2040-2295.1.2.185

M3 - Article

AN - SCOPUS:79954497548

VL - 1

SP - 185

EP - 196

JO - Journal of Healthcare Engineering

JF - Journal of Healthcare Engineering

SN - 2040-2295

IS - 2

ER -